Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 8—August 2017
Synopsis

Added Value of Next-Generation Sequencing for Multilocus Sequence Typing Analysis of a Pneumocystis jirovecii Pneumonia Outbreak1

Elena Charpentier, Cécile Garnaud, Claire Wintenberger, Sébastien Bailly, Jean-Benjamin Murat2, John Rendu, Patricia Pavese, Thibault Drouet, Caroline Augier, Paolo Malvezzi, Anne Thiébaut-Bertrand, Marie-Reine Mallaret, Olivier Epaulard, Muriel Cornet, Sylvie Larrat, and Danièle MaubonComments to Author 
Author affiliations: Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France (E. Charpentier, C. Garnaud, C. Wintenberger, J.-B. Murat, J. Rendu, P. Pavese, T. Drouet, C. Augier, P. Malvezzi, A. Thiébaut-Bertrand, M.-R. Mallaret, O. Epaulard, M. Cornet, S. Larrat, D. Maubon); Université Grenoble Alpes, Grenoble (E. Charpentier, C. Garnaud, M.-R. Mallaret, O. Epaulard, M. Cornet, S. Larrat, D. Maubon); Institut National de la Santé et de la Recherche Médicale Université Paris Diderot, Paris, France (S. Bailly).

Main Article

Table 2

Results of next-generation multilocus sequence typing for the 3 targeted loci of Pneumocystis jirovecii strains in a study of a P. jirovecii pneumonia outbreak at a university hospital in France, 2014–2015*

Patient mtLSU
CYTB
SOD
Final major genotype
No. reads No. haplotypes Major haplotype No. reads No. haplotypes Major haplotype No. reads No. haplotypes Major haplotype
T1 1,413 1 B 531 1 1 946 1 A B1a
T2 1,062 1 C 1,361 1 2 2,506 1 A C2a
T3 638 4 N 84 1 3 491 1 B N3b
T4 87 1 C 215 1 2 204 1 A C2a
T5 460 1 C 1,030 1 2 337 1 A C2a
T6 42 1 E 237 1 2 171 1 A E2a
T7 546 1 C 1,088 1 2 303 4 B C2b†
T8 606 2 C 1,136 2 2 808 1 A C2a
T9 194 1 C 160 1 2 8 1 B C2b
T10 415 1 C 1,360 1 2 898 1 A C2a
T11 420 3 O 370 2 1 298 3 B O1b
T12 658 9 F 809 4 3 781 1 A F3a
C1 318 3 P 1,046 1 3 1,268 1 A P3a
C2 422 8 B 339 4 3 364 2 A ND
C3 350 1 I 564 1 3 1,268 1 B I3b
C4 292 2 N 492 1 3 427 1 B N3b
C5 71 1 B 651 1 2 880 1 B B2b
C6 368 12 P 473 3 3 575 4 B ND
C7 153 2 F 103 2 3 54 4 A F3a
C8 383 5 I 697 2 3 653 4 B ND
C9 148 2 F 104 4 2 154 1 a F2a
C10 934 2 F 1,146 5 2 550 3 a F2a
C11 229 4 B 750 3 3 119 2 b B3b
C12 580 2 G 398 1 1 509 1 a G1a
C13 869 1 F 1,998 1 3 663 1 a F3a
C14 901 9 B 1,403 1 2 411 1 b B2b
C15 653 1 N 1,664 2 3 5 1 a N3a
C16 1,275 1 F 1,052 1 11 591 1 a F11a
C17 372 10 P 434 3 2 361 1 b ND
C18 296 1 F 271 1 3 15 3 b F3b
C19 948 2 F 795 4 1 494 1 a ND
C20 243 5 A 284 9 2 240 2 b ND

*T1–T12 indicate the 12 solid organ transplant patients from the cluster; C1–C20 indicate the 20 control patients. Underlined genotypes were included for Hunter Index calculation. CYTB, cytochrome b; mtLSU, mitochondrial large subunit of ribosomal RNA; ND, undetermined genotypes when haplotypes could not be cross-linked (multiple variants in >1 locus without any clear predominance); SOD, superoxide dismutase.
†Patient carrying the C2a genotype as a minor strain.

Main Article

1Preliminary results from this study were presented at the American Society for Microbiology Microbe 2016 Conference, June 16–20, 2016, Boston, Massachusetts, USA.

2Current affiliation: Centre Hospitalier Universitaire Limoges, Limoges, France.

Page created: July 17, 2017
Page updated: July 17, 2017
Page reviewed: July 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external